Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy.

Autor: Courlet P; Precision Oncology Center, Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Abler D; Precision Oncology Center, Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Institute of Informatics, School of Management, University of Applied Sciences Western Switzerland (HES-SO), Sierre, Switzerland., Guidi M; Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Service of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Girard P; Merck Institute of Pharmacometrics, Ares Trading S.A. (an affiliate of Merck KGaA, Darmstadt, Germany), Lausanne, Switzerland., Amato F; Swiss Data Science Centre, École Polytechnique Fédérale de Lausanne (EPFL) and Eidgenössische Technische Hochschule Zurich (ETH), Zurich, Switzerland., Vietti Violi N; Department of Radiology and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Dietz M; Nuclear Medicine and Molecular Imaging Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Guignard N; Department of Radiology and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Wicky A; Precision Oncology Center, Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Latifyan S; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., De Micheli R; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Jreige M; Nuclear Medicine and Molecular Imaging Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Dromain C; Department of Radiology and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Csajka C; Centre for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Geneva, Switzerland.; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland., Prior JO; Nuclear Medicine and Molecular Imaging Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Venkatakrishnan K; EMD Serono Research and Development Institute, Inc, Billerica, Massachusetts, USA., Michielin O; Precision Oncology Center, Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Cuendet MA; Precision Oncology Center, Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, University of Lausanne, Lausanne, Switzerland.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA., Terranova N; Merck Institute of Pharmacometrics, Ares Trading S.A. (an affiliate of Merck KGaA, Darmstadt, Germany), Lausanne, Switzerland.

Publikováno v: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Aug; Vol. 12 (8), pp. 1170-1181. Date of Electronic Publication: 2023 Jun 16.

Interactive process mining of cancer treatment sequences with melanoma real-world data.

Autor: Wicky A; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Gatta R; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Dipartimento di Scienze Cliniche e Sperimentali dell'Università degli Studi di Brescia, Brescia, Italy., Latifyan S; Medical Oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Micheli R; Medical Oncology, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Gerard C; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Pradervand S; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Michielin O; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, University of Lausanne, Lausanne, Switzerland., Cuendet MA; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, University of Lausanne, Lausanne, Switzerland.; Department of Physiology and Medicine, Weill Cornell Medicine, New York, NY, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Mar 21; Vol. 13, pp. 1043683. Date of Electronic Publication: 2023 Mar 21 (Print Publication: 2023).

A differential process mining analysis of COVID-19 management for cancer patients.

Autor: Cuendet MA; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, United States., Gatta R; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Wicky A; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Gerard CL; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; The Francis Crick Institute, London, United Kingdom., Dalla-Vale M; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Tavazzi E; Department of Information Engineering, University of Padova, Padova, Italy., Michielin G; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Delyon J; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Ferahta N; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Cesbron J; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Lofek S; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Huber A; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Jankovic J; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Demicheli R; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Bouchaab H; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Digklia A; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Obeid M; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Peters S; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Eicher M; Department of Oncology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Institute of Higher Education and Research in Health Care, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland., Pradervand S; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Michielin O; Precision Oncology Center, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Publikováno v: Frontiers in oncology [Front Oncol] 2022 Dec 07; Vol. 12, pp. 1043675. Date of Electronic Publication: 2022 Dec 07 (Print Publication: 2022).

Structural Prediction of Peptide-MHC Binding Modes.

Autor: Perez MAS; Computer-aided Molecular Engineering Group, Department of Oncology UNIL-CHUV, Lausanne University, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland.; Molecular Modelling Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Cuendet MA; Molecular Modelling Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Precision Oncology Center, Lausanne, Switzerland., Röhrig UF; Molecular Modelling Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Michielin O; Molecular Modelling Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland. olivier.michielin@chuv.ch.; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Precision Oncology Center, Lausanne, Switzerland. olivier.michielin@chuv.ch., Zoete V; Computer-aided Molecular Engineering Group, Department of Oncology UNIL-CHUV, Lausanne University, Lausanne, Switzerland. vincent.zoete@unil.ch.; Ludwig Institute for Cancer Research, Lausanne, Switzerland. vincent.zoete@unil.ch.; Molecular Modelling Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland. vincent.zoete@unil.ch.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2405, pp. 245-282.